Abstract:Abstract Introduction In the acute phase following a stroke, circadian rhythmicity is often disrupted, which undermines sleep, produces fatigue, and impedes recovery. Studies have reported post-stroke sleep architecture abnormalities, as well as acute sleep disorders which can range between extremes of clinically significant insomnia to hypersomnia, with sleep complaints sometimes persisting for months or years. Morning blue light exposure as an early, non-pharmacologic intervention targeted for strengthening circadian rhythmicity could provide acute relief and prevent disordered sleep from becoming chronic following stroke. Methods A randomized, single-blind, parallel group, placebo-controlled pilot study compared daily morning exposure to blue light or red light (placebo) for improving daytime sleepiness, fatigue, nocturnal sleep, and cognition in patients receiving inpatient rehabilitation for acute stroke. N=43 patients with disordered sleep secondary to first episode stroke (n=34 ischemic, n=9 hemorrhagic; ages 66.2±14.1y) were randomized to receive 25min of morning blue or red light for 5 or more days depending on inpatient rehabilitation length of stay (blue n=21, red n=22). At baseline and study discharge, daytime sleepiness was measured with the Karolinska Sleepiness Scale and Wits Pictorial Sleepiness Scale, fatigue with a visual analogue scale, and cognitive function with the Rey Auditory Verbal Learning Test and Trail Making Test (TMT). Actigraphy measured sleep continuously throughout participation with nighttime sleep defined as 21:00–05:59. Effect sizes per outcome were used to estimate sample sizes for larger follow-up studies. Results Participants with blue light exposure experienced significant improvements in daytime sleepiness, fatigue, and auditory verbal learning (all p<.05) relative to red light exposure. There was a trend toward a greater mean duration of nighttime sleep (p=.076) and fewer awakenings after sleep onset (p=.092) in the blue light compared to red light group. Although change in TMT and nocturnal sleep parameters did not reach statistical significance, effect sizes favored blue-light exposure, ranging from .38–.57. Conclusion Morning blue light exposure for 5 or more days led to greater improvements in daytime sleepiness, fatigue, and cognitive outcomes than red light exposure after acute stroke. Effect sizes suggest a larger study is warranted to confirm generalizability of pilot findings. Support (if any) Empire Health Foundation

A double‐blind, randomized, placebo‐controlled trial of adjunctive blue‐blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder

BLUES - stabilizing mood and sleep with blue blocking eyewear in bipolar disorder - a randomized controlled trial study protocol

Modelling the effect of light through commercially available blue-blocking lenses on the human circadian system

The effect of blue-blocking intraocular lenses on circadian biological rhythm: protocol for a randomised controlled trial (CLOCK-IOL colour study)

0623 Effects of bright light therapy on objective and subjective sleep in patients with non-seasonal depression and eveningness

Sleep and circadian rhythm disturbance in bipolar disorder

Objective and subjective sleep in patients with non-seasonal major depressive disorder and eveningness – Results from a randomized controlled trial of bright light therapy

Circadian rhythm in bipolar disorder: A review of the literature

Bright light therapy and early morning attention, mathematical performance, electroencephalography and brain connectivity in adolescents with morning sleepiness

Effects of monochrome blue LED light on healthy human circadian rhythm

Long-Term Reduction of Short-Wavelength Light Affects Sustained Attention and Visuospatial Working Memory With No Evidence for a Change in Circadian Rhythmicity

Minimal Effects of Binaural Auditory Beats for Subclinical Insomnia: A Randomized Double-Blind Controlled Study

1003 Daily Morning Blue Light Exposure for Alertness and Sleep Following Stroke

Positive effect of timed blue-enriched white light on sleep and cognition in patients with mild and moderate Alzheimer’s disease

Are circadian rhythms more favorable with lithium than with other mood stabilizers? An exploratory actigraphy study in euthymic bipolar disorder type 1

Metabolic syndrome and actigraphy measures of sleep and circadian rhythms in bipolar disorders during remission

Treating insomnia improves mood state, sleep, and functioning in bipolar disorder: A pilot randomized controlled trial.

Associations between actigraphy estimates of sleep and circadian rhythmicity and psychotropic medications in bipolar disorders: An exploratory study

A randomized controlled trial to compare the effects of time-restricted eating versus Mediterranean diet on symptoms and quality of life in bipolar disorder

Association of functioning and quality of life with objective and subjective measures of sleep and biological rhythms in major depressive and bipolar disorder

Light Therapy for Patients With Bipolar Depression: Systematic Review and Meta-Analysis of Randomized Controlled Trials